Experience of

M M Bikbov; Z A Dautova; F Kh Kamilov; Regina Ramilevna Samatova; M M Bikbov; Z A Dautova; F Kh Kamilov; R R Samatova

doi:10.17816/rpoj37445

Russian Pediatric Ophthalmology ›› 2011, Vol. 6 ›› Issue (1) : 28 -31. DOI: 10.17816/rpoj37445

Articles

other

Experience of "Chondroitin-AKOS" drug application in progressive myopia treatment in children

Author information +

History +

PDF

Abstract

Progressive myopia remains a topical problem of modern ophthalmology. The article in question presents the dynamics of visual functions indices and connective tissue metabolism in treatment by "Chondroitin-AKOS" drug in 40 children with progressive moderate and high myopia.It was detected as follows: visual acuity improvement, increase of volume and resource of relative accommodation, increase of type I carboxi-propeptide-procollagen level in blood, decrease of the oligomerous matrix protein of cartilage and cartilaginous glycoprotein-39. The analysis of visual functions, anterior-posterior size value of the eye 6 months later has shown that medical effect of the drug still remained.

Keywords

children / progressive myopia / connective tissue / visual acuity / accommodation

Cite this article

Download citation ▾

M M Bikbov, Z A Dautova, F Kh Kamilov, Regina Ramilevna Samatova, M M Bikbov, Z A Dautova, F Kh Kamilov, R R Samatova. Experience of "Chondroitin-AKOS" drug application in progressive myopia treatment in children. Russian Pediatric Ophthalmology, 2011, 6(1): 28-31 DOI:10.17816/rpoj37445

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Аветисов Э. С. Близорукость. - М., 2002.

[2]	Бикбов М. М., Даутова З. А., Саматова Р. Р. и др. Некоторые биохимические показатели крови при приобретенной близорукости у детей // Вестн. Рос. Воен.-мед. акад. - 2009. - № 3. - С. 52-54.

[3]	Винецкая М. И., Болтаева З. К., Иомдина Е. Н., Андреева Л. Д. Биохимические аспекты прогрессирующей миопии // Офтальмол. журн. - 1988. - № 3. - С. 155-158.

[4]	Даниличев В. Ф. Патология глаз. Ферменты и ингибиторы. - М., 1996.

[5]	Либман Е. С., Шахова Е. В. // Ликвидация устранимой слепоты: всемирная инициатива ВОЗ: Материалы Российского межрегионального симпозиума. - М., 2003. - С. 38-43.

[6]	Справочник Видаль. - М., 2008.

[7]	Тарутта Е. П. Возможности профилактики прогрессирующей и осложненной миопии в свете современных знаний о ее патогенезе // Вестн. офтальмол. - 2006. - № 1. - С. 43-47.

[8]	Bruzere O., Collete J. H., Ethgen O. et al. Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis // J. Rheumatol. - 2003. - Vol. 30. - P. 1043-1050.

[9]	Curtin B. J. The Myopias. Basic science and clinical management. - Philadelphia, 1985.

[10]	Ebeling P. R., Peterson J. M., Riggs B. L. Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases // J. Bone Miner. Res. - 1992. - Vol. 7. - P. 1243-1250.

[11]	Johansen J. S., Jensen H. S., Price P. A. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid // Br. J. Rheumatol. - 1993. - Vol. 32. - P. 949- 955.